Literature DB >> 28176190

Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.

Gaeun Kim1, Ji Hye Huh2, Kyong Joo Lee2, Moon Young Kim2,3, Kwang Yong Shim2, Soon Koo Baik4,5,6.   

Abstract

BACKGROUND: Relative adrenal insufficiency (RAI) is frequently observed in patients with cirrhosis. We sought to identify evidence in the literature regarding the impact of RAI on clinical outcomes in cirrhotic patients.
METHODS: We conducted a systematic review (SR) and meta-analysis (MA) using the Ovid-MEDLINE, EMBASE, and Cochrane Library databases to identify relevant studies in the literature.
RESULTS: Of the 182 studies identified, 16 were eligible according to our inclusion criteria. The prevalence of RAI was 49.4% (744/1507), and cirrhotic patients with acute critical illnesses such as sepsis were more likely to have RAI compared to those without critical illnesses (P < 0.001). With respect to clinical outcomes, patients with RAI had poorer survival rates and an increased risk of complications such as bleeding and hepatorenal syndrome compared to those without RAI. Corticosteroid therapy had a beneficial effect on critically ill cirrhotic patients in terms of hospital survival rate.
CONCLUSIONS: Based on this SR and MA, critically ill patients with cirrhosis have a high risk of RAI, and the presence of RAI is related to a poor prognosis and occurrence of cirrhotic complications.

Entities:  

Keywords:  Adrenal insufficiency; Cirrhosis; Meta-analysis; Systematic review

Mesh:

Year:  2017        PMID: 28176190     DOI: 10.1007/s10620-017-4471-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  46 in total

Review 1.  Corticosteroid insufficiency in acutely ill patients.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

2.  Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease.

Authors:  Terrence Tan; Linus Chang; Aidan Woodward; Brett McWhinney; John Galligan; Graeme A Macdonald; Jeremy Cohen; Bala Venkatesh
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

3.  Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation.

Authors:  Pierluigi Toniutto; Carlo Fabris; Elisa Fumolo; Davide Bitetto; Ezio Fornasiere; Edmondo Falleti; Rachele Rapetti; Rosalba Minisini; Mario Pirisi
Journal:  Liver Transpl       Date:  2008-07       Impact factor: 5.799

4.  Critical illness-related corticosteroid insufficiency in patients with cirrhosis and variceal bleeding.

Authors:  Christos K Triantos; Michel Marzigie; Giuseppe Fede; Marina Michalaki; Dimitra Giannakopoulou; Konstantinos Thomopoulos; Matteo Garcovich; Maria Kalafateli; Aris Chronis; Venetsana Kyriazopoulou; Eleni Jelastopoulou; Vasiliki Nikolopoulou; James O'Beirne; Andrew K Burroughs
Journal:  Clin Gastroenterol Hepatol       Date:  2011-04-08       Impact factor: 11.382

5.  The hepatoadrenal syndrome: a common yet unrecognized clinical condition.

Authors:  Paul E Marik; Timothy Gayowski; Thomas E Starzl
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598

6.  Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial.

Authors:  Ki Tae Suk; Jung-Hwan Yoon; Moon Young Kim; Chang Wook Kim; Ja Kyung Kim; Hana Park; Seong Gyu Hwang; Dong Joon Kim; Byung Seok Lee; Sae Hwan Lee; Hong Soo Kim; Jae Young Jang; Chang-Hyeong Lee; Byung Seok Kim; Yoon Ok Jang; Mee Yon Cho; Eun Sun Jung; Yong Man Kim; Si Hyun Bae; Soon Koo Baik
Journal:  Hepatology       Date:  2016-07-30       Impact factor: 17.425

7.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

8.  Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long-term mortality.

Authors:  J Y Jang; T Y Kim; J H Sohn; T H Lee; S W Jeong; E J Park; S H Lee; S G Kim; Y S Kim; H S Kim; B S Kim
Journal:  Aliment Pharmacol Ther       Date:  2014-07-30       Impact factor: 8.171

Review 9.  Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Gaeun Kim; Kwang Yong Shim; Soon Koo Baik
Journal:  Gut Liver       Date:  2017-01-15       Impact factor: 4.519

Review 10.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

View more
  7 in total

1.  Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.

Authors:  Ki Tae Suk; Moon Young Kim; Soung Won Jeong; Jae Young Jang; Yoon Ok Jang; Soon Koo Baik
Journal:  Dig Dis Sci       Date:  2017-12-01       Impact factor: 3.199

Review 2.  KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-07-09

Review 3.  Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.

Authors:  Kwang Yong Shim; Young Woo Eom; Moon Young Kim; Seong Hee Kang; Soon Koo Baik
Journal:  Korean J Intern Med       Date:  2018-02-21       Impact factor: 2.884

Review 4.  Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.

Authors:  Gaeun Kim; Seong Hee Kang; Moon Young Kim; Soon Koo Baik
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

Review 5.  Progress of Interference of Traditional Chinese Medicine on Cirrhosis Treated with Bone Marrow Mesenchymal Stem Cells.

Authors:  Yaxin Wang; Huicun Zhang; Hongbing Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-11       Impact factor: 2.629

Review 6.  Adrenal Insufficiency in Cirrhosis.

Authors:  Brian J Wentworth; Helmy M Siragy
Journal:  J Endocr Soc       Date:  2022-07-29

7.  Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways.

Authors:  Kyong Joo Lee; Yoon Ok Jang; Seung-Kuy Cha; Moon Young Kim; Kyu-Sang Park; Young Woo Eom; Soon Koo Baik
Journal:  Gut Liver       Date:  2018-07-15       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.